Review of ECMO support at the University Hospital of Martinique
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation, Infections, Lungs & breathing clinical trials.
This study looks at all patients who received ECMO (a machine that helps the heart and lungs) at the University Hospital of Martinique. It is a registry study, meaning it simply collects information from your medical records to learn more about how ECMO is used and how patients do.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated with a type of life support called ECMO (which helps your heart and lungs work) at the University Hospital of Martinique.
- Your treatment happened any time from January 2010 onward.
- Your medical records are complete enough for the study to use (no major missing information).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information about people who are placed on ECMO, a heart-lung machine used to support breathing and/or circulation. It may help doctors better understand who benefits and how to manage ECMO in the future.
This is a research registry for adults who need a breathing and/or heart support machine called ECMO while in the hospital. It collects information to better understand who receives ECMO and how patients do over time.
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
This study tests a specific heart-lung machine called Cardiohelp to help children with severe heart failure. It looks at how well the machine works and whether a blood thinner (either heparin or bivalirudin) is safer and more effective.
This study is a registry that collects information from adults who need a temporary heart circulation support device such as VA-ECMO or an Impella pump (or newer similar devices). It may help doctors better understand which patients benefit most and how these devices are used in real life.
This trial tests a device that helps support your heart when it's in cardiogenic shock (a life-threatening condition where the heart can't pump enough blood). The device works alongside standard treatments to improve blood flow and reduce strain on the heart.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.